Unravelling the distinct effects of VHL mutations and chromosome 3p loss in clear cell renal cell carcinoma: Implications for prognosis and treatment

Documenti analoghi

• Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
  di: Bin Zheng, et al.
  Pubblicazione: (2024)
• METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination
  di: Zhuonan Liu, et al.
  Pubblicazione: (2025)
• Plasma tsRNAs as novel diagnostic biomarkers for renal cell carcinoma
  di: Meng Ding, et al.
  Pubblicazione: (2024)
• B‐cell performance in chemotherapy: Unravelling the mystery of B‐cell therapeutic potential
  di: Zizhuo Li, et al.
  Pubblicazione: (2024)
• Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma
  di: Lin Yang, et al.
  Pubblicazione: (2025)